• \
    Start Submission Become a Reviewer

    Reading: MPO-ANCA Associated Vasculitis Following COVID-19 Vaccination – A Case Report

    Download

     A- A+
    Alt. Display

    Published Abstracts

    MPO-ANCA Associated Vasculitis Following COVID-19 Vaccination – A Case Report

    Authors:

    Mahmoud Khalifa ,

    BronxCare Health System, US
    X close

    Yara Adel Altahan,

    Royal College of Surgeons in Ireland, RCSI, IE
    X close

    Paavana Varanasi

    BronxCare Health System, US
    X close

    Abstract

    Whether autoimmune or rheumatic disease can be precipitated after vaccination is controversial. Only epidemiological studies or clinical trials with an extremely large sample size can allow for a consistent assessment of the relative risk of vaccine-related incidence. Studies with such large sample sizes are complex, difficult to perform, and costly, which limit their administration. There exists no minimum criteria for diagnosing vaccine-related autoimmune diseases, this question must be analyzed on a case-by-case basis.

    Although our report does not prove a causal association between vaccination and vasculitis, it seems possible that in rare cases, vaccination might induce vasculitic disease. While the possibility of autoimmune disease is very real, without vaccinations the SARS-CoV-2 pandemic will spread unchecked, bringing with it a slew of multisystem disorders, including autoimmune diseases both in the present and future (Table 1, Figures 1, 2).

    Keywords: COVID-19 vaccination, MPO-ANCA, Vasculitis, Autoimmune, SARS-CoV-2, COVID-19
    How to Cite: Khalifa, M., Altahan, Y.A. and Varanasi, P., 2021. MPO-ANCA Associated Vasculitis Following COVID-19 Vaccination – A Case Report. Journal of Scientific Innovation in Medicine, 4(2), p.5. DOI: http://doi.org/10.29024/jsim.101
    404
    Views
    74
    Downloads
      Published on 24 May 2021
     CC BY 4.0
     Accepted on 04 May 2021            Submitted on 04 May 2021

    Table 1

    Results of the workup for renal failure.

    ACUTE-KIDNEY INJURY WORK UP REQUESTED RESULT
    C3 135.0 [90.0–150.0 mg/dL]
    C4 20.0 [16.0–47.0 mg/dL]
    Anti-nuclear antibody (ANA) screen Negative
    Anti-Glomerular basement membrane antibody Undetectable
    Anti-DNA antibody Undetectable
    ANCA-MPO antibody 535.4 AI
    ANCA-Proteinase-3 antibody Undetectable
    Figure 1 

    CXR showing diffuse bilateral interstitial/alveolar airspace infiltrates.
    Figure 2 

    HRCT chest showing spiculated densities in the bilateral lung apices.

    Competing Interests

    The authors have no competing interests to declare.

    Jump to Discussions
    comments powered by Disqus